Monthly Archives: November 2013

Eurocor Announces Interim Results of the Freeway Stent Study

FREEWAY014035_perspective_lg

Eurocor GmbH, an Opto Circuits group company, unveiled 6 and 12 months insights of the ongoing Freeway Stent Study during the TCT Congress in San Francisco on October 29th, 2013. … read more

Eurocor’s Valentines Trial II published in EuroIntervention

EUROCOR DIOR

The Valentines Trial II conducted by Eurocor GmbH, an Opto Circuits group company, was a worldwide multicenter enrollment trial evaluating the real world usage of the second generation DIOR® paclitaxel … read more